Pay in 4 interest-free payments of $87.50 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
the sialylation of therapeutic proteins can affect their serum half-life
C28H41D3O / 399
This probe can be used as a soluble inhibitor or immobilized on plates or sensors to investigate binding
N-α-Fmoc-O-β-(2-acetamido-3
GalNAcα(1-3)[Fucα(1-2)]Gal-β-O-(CH2)8-C(O)NH-(CH2)2-NH-biotin
GP000100: MUC1(126-149)-STn(130,131) Pack Size:1 mg the sialylation of therapeutic proteinsC133H209N33O58 3198. 27 MUC1 (UniProt ID P15941) synthetic glycopeptide fragment (Pro126 Gly149; UniProt position 126 149, aa length 24) from the variable number tandem repeat (TR) domain. The fragment contains tumour associated carbohydrate antigen (TACA), Sialyl Tn or STn (Neu5Ac2 6GalNAc O Ser) at Ser130 and Neu5Ac2 6GalNAc O Thr at Thr131. The C terminus is carboxylic acid. MUC1(126 149) STn(130,131) Mucin1; Synthetic MUC 1 (di STn) glycopeptide
